NeuroPace, Inc. [l] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • April 14th, 2021 • NeuroPace Inc • Surgical & medical instruments & apparatus • New York
NeuroPace, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [l] shares of common stock, par value $[l] per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [l] shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
INDEMNITY AGREEMENTIndemnity Agreement • April 14th, 2021 • NeuroPace Inc • Surgical & medical instruments & apparatus • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of ____________, is made by and between NEUROPACE, INC., a Delaware corporation (the “Company” or “NeuroPace” ), and ____________ (“Indemnitee” ).
SUPPLY AGREEMENTSupply Agreement • April 14th, 2021 • NeuroPace Inc • Surgical & medical instruments & apparatus • Delaware
This Supply Agreement (“Supply Agreement”), is entered into as of the 16th day of November, 2015. (the “Effective Date”), by and between NeuroPace, Inc., a Delaware corporation located at 455 N. Bernardo Avenue, Mountain View, California, 94043 USA (“COMPANY”) and Micro Systems Technologies Management AG, a Swiss corporation, located at [***] (“MST”). COMPANY and MST may be individually referred to herein as “Party” and collectively as “Parties”.
SUPPLY AGREEMENTSupply Agreement • April 14th, 2021 • NeuroPace Inc • Surgical & medical instruments & apparatus • New York
This Supply Agreement (this “Agreement”), dated as of January 01, 2021 (the “Effective Date”), is by and between Greatbatch Ltd., an Integer company, with an office at [***] (“Greatbatch”), and NeuroPace, Inc., with an office at 455 N. Bernardo Avenue, Mountain View, California 94043 (“NeuroPace”).
NEUROPACE, INC. STOCK OPTION AGREEMENTEquity Incentive Plan • April 14th, 2021 • NeuroPace Inc • Surgical & medical instruments & apparatus
As reflected by your Stock Option Grant Notice (“Grant Notice”) NeuroPace, Inc. (the “Company”) has granted you an option under its 2021 Equity Incentive Plan (the “Plan”) to purchase a number of shares of Common Stock at the exercise price indicated in your Grant Notice (the “Option”). Capitalized terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan shall have the meanings set forth in the Grant Notice or Plan, as applicable. The terms of your Option as specified in the Grant Notice and this Stock Option Agreement constitute your Option Agreement.
AMENDMENT ONE TO THE SUPPLY AGREEMENTSupply Agreement • April 14th, 2021 • NeuroPace Inc • Surgical & medical instruments & apparatus
This Amendment One to the Supply Agreement (“Amendment One”) dated November 16, 2015 (the “Supply Agreement”), is entered into as of the 21st day of December 2020, by and between NeuroPace, Inc., a Delaware corporation located at 455 N. Bernardo Avenue, Mountain View, California, 94043 USA (“COMPANY”) and Micro Systems Engineering, Inc., a Delaware corporation with offices located at [***] (“MST”). COMPANY and MST may be individually referred to herein as “Party” and collectively as “Parties”.
